Erratum: MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelialmesenchymal transition regulator (Molecular Medicine Reports (2016) 13 (3349-3355) DOI: 10.3892/mmr.2016.4901);MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator

Molecular Medicine Reports

Volumn 13, Issue 4, 2016, Pages 3349-3355

  Jiao, Aihong ^a,b   Sui, Minghua ^b   Zhang, Liangming ^b   Sun, Ping ^b   Geng, Dongmei ^b   Zhang, Weiwei ^b   Wang, Xiuwen ^a   Li, Junxia ^b  

^a SHANDONG UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Epithelial mesenchymal transition; Metastasis; MicroRNA; Non small cell lung cancer; Zinc finger E box binding homeobox 2

Indexed keywords

COMPLEMENTARY DNA; MICRORNA 200C; NERVE CELL ADHESION MOLECULE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZINC FINGER E BOX BINDING HOMEOBOX 2; ZINC FINGER PROTEIN; 3' UNTRANSLATED REGION; ANTISENSE OLIGONUCLEOTIDE; CADHERIN; HOMEODOMAIN PROTEIN; MICRORNA; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; A549 CELL LINE; ARTICLE; BASE PAIRING; CELL INVASION; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUCIFERASE ASSAY; METASTASIS; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; A-549 CELL LINE; ANTAGONISTS AND INHIBITORS; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; LUNG TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA INTERFERENCE; SEQUENCE ALIGNMENT;

3' UNTRANSLATED REGIONS; A549 CELLS; BASE SEQUENCE; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENES, REPORTER; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; UP-REGULATION; VIMENTIN;

EID: 84963838733     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2021.12212     Document Type: Erratum

References (24)

1. DeSantis C, Ma J, Bryan L and Jemal A: Breast cancer statistics, 2013. CA Cancer J Clin 64: 52-62, 2014.
2. Dimou A and Papadimitrakopoulou V: Non-Small cell lung cancer beyond biomarkers: The evolving landscape of clinical trial design. J Pers Med 4: 386-401, 2014.
3. Chouaid C, Crequit P, Borget I and Vergnenegre A: Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: A systematic review. Clinicoecon Outcomes Res 7: 9-15, 2014.
4. Moss EG: MicroRNAs: Hidden in the genome. Curr Biol 12: R138-R140, 2002.
5. Choi E, Choi E and Hwang KC: MicroRNAs as novel regulators of stem cell fate. World J Stem Cells 5: 172-187, 2013.
6. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al: A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105: 13556-13561, 2008.
7. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
8. Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M and Allgayer H: Loss of MIR-200c expression induces an aggressive, invasive and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res 8: 1207-1216, 2010.
9. Li J, Tan Q, Yan M, Liu L, Lin H, Zhao F, Bao G, Kong H, Ge C, Zhang F, et al: miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. Mol Cancer 13: 166, 2014.
10. Shi L, Zhang S, Wu H, Zhang L, Dai X, Hu J, Xue J, Liu T, Liang Y and Wu G: MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway. PLoS One 8: e78344, 2013.
11. Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, Verschueren K, Smith JC and Huylebroeck D: New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 18: 5073-5084, 1999.
12. Nam EH, Lee Y, Park YK, Lee JW and Kim S: ZEB2 upregulates integrin alpha5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. Carcinogenesis 33: 563-571, 2012.
13. You J, Li Y, Fang N, Liu B, Zu L, Chang R, Li X and Zhou Q: MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PLoS One 9: e91827, 2014.
14. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
15. Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum MIR-21 and tumor MIR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 29: 618-626, 2012.
16. Tejero R, Navarro A, Campayo M, Viñolas N, Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L, Ramirez J and Monzó M: MIR-141 and MIR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma. PLoS One 9: e101899, 2014.
17. Yang X, Wang J, Qu S, Zhang H, Ruan B, Gao Y, Ma B, Wang X, Wu N, Li X, et al: MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2. Oncotarget 6: 7918-7929, 2015.
18. Zhou X, Wang Y, Shan B, Han J, Zhu H, Lv Y, Fan X, Sang M, Liu XD and Liu W: The downregulation of MIR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. Med Oncol 32: 428, 2015.
19. Chen Z, Tang ZY, He Y, Liu LF, Li DJ and Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma. Oncol Res Treat 37: 658-664, 2014.
20. Guo F, Cogdell D, Hu L, Yang D, Sood AK, Xue F and Zhang W: MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Oncol Rep 31: 2021-2028, 2014.
21. Qi S, Song Y, Peng Y, Wang H, Long H, Yu X, Li Z, Fang L, Wu A, Luo W, et al: ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion and apoptosis in glioma. PLoS One 7: e38842, 2012.
22. Usova EV, Kopantseva MR, Kostina MB, Van'kovich AN, Egorov VI and Kopantsev EP: Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis and normal state. Dokl Biol Sci 448: 61-64, 2013.
23. Fang S, Zeng X, Zhu W, Tang R, Chao Y and Guo L: Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by MIR-200b contributes to multi-drug resistance of small cell lung cancer. Exp Mol Pathol 96: 438-444, 2014.
24. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ: The MIR-200 family and MIR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601, 2008.